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Available online 28 October 2016Stem cells have a high therapeutic potential for the treatment of spinal cord injury (SCI). We have shown previ-
ously that endogenous stem cell potential is conﬁned to ependymal cells in the adult spinal cord which could be
targeted for non-invasive SCI therapy. However, ependymal cells are an understudied cell population. Taking ad-
vantage of transgenic lines, we characterize the appearance and potential of ependymal cells during develop-
ment. We show that spinal cord stem cell potential in vitro is contained within these cells by birth. Moreover,
juvenile cultures generatemore neurospheres andmore oligodendrocytes than adult ones. Interestingly, juvenile
ependymal cells in vivo contribute to glial scar formation after severe but not mild SCI, due to a more effective
sealing of the lesion by other glial cells. This study highlights the importance of the age-dependent potential of
stem cells and post-SCI environment in order to utilize ependymal cell's regenerative potential.








Spinal cord injury (SCI) is currently a chronic incurable disease with
reported incidences ranging from 9.2 to 246 cases per million of the
population a year depending on the area surveyed (Siddiqui et al.,
2015). The majority of affected people are 10–40 years old at the time
of injury (Siddiqui et al., 2015) and it deeply affects the quality and ex-
pectancy of life in young people (The National Spinal Cord Injury
Statistical Center, 2015). Indeed, SCI typically results in permanent func-
tional impairment in locomotion and sensation below the injury level,
and can also cause neuropathic pain, spasticity and incontinence
(Westgren and Levi, 1998).
Upon traumatic injury, the cellular and molecular response of the
spinal cord is complex and characterized by acute and chronic phases
(Silver and Miller, 2004). The spinal cord attempts repair but it is
never complete (Silver and Miller, 2004). The key factors leading to
the lack of complete regeneration and recovery of function are thet of Neuroscience, Karolinska
uérout),
are co-ﬁrst authors.
. This is an open access article underformation of an inhibitory glial environment, neural cell death, demye-
lination, axonal degeneration and lack of regrowth and inﬂammatory
response (Barnabe-Heider and Frisen, 2008; Gregoire et al., 2015).
Even though it has been suggested that the glial scar has inhibitory
effects on self-repair and neuroregeneration after SCI, recent studies
showed that astrocytes, ependymal and inﬂammatory cells have also
pro-regenerative properties (Anderson et al., 2016; Barnabe-Heider et
al., 2010; Rolls et al., 2009; Sabelstrom et al., 2013). Indeed, the central
nervous system shows an innate ability to partially regenerate after
traumas (Gregoire et al., 2015). At the anatomical level, the glial scar
can be divided into two regions: the border, rimmed primarily by resi-
dent reactive astrocytes, and the lesion core, formed mainly by migrat-
ing ependymal cells and inﬁltrating stromal cells (Barnabe-Heider et al.,
2010; Goritz et al., 2011; Sabelstrom et al., 2014). Therapeutically, sev-
eral regenerative approaches have been tested to cure SCI, such as
stem cell transplantation (Charsar et al., 2016; Granger et al., 2014).
However, these studies have shown beneﬁcial effects in animal models
but have important practical limitations in a human context (Granger et
al., 2014; Charsar et al., 2016). An alternative way will be to recruit and
activate endogenous stem cells after SCI (Qin et al., 2015).
During adulthood, the spinal cord stem cell potential is restricted to
ependymal cells, the cell population surrounding the central canal
(Barnabe-Heider et al., 2010; Meletis et al., 2008). Ependymal cells are
activated by traumatic SCI, self-renew and differentiate into astrocytesthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Antibody table. Details of sources and concentrations of antibodies used for histo/immu-
nochemistry in this study.
Antibody table
Antibody Species Dilution Company (Catalog#)
GFP Chicken 1:500 Aves (GFP-1020)
Ki-67 Rabbit 1:500 ThermoScientiﬁc (RM-9106)
GFAP Rabbit 1:500 Millipore (AB5804)
Iba1 Rabbit 1:200 Wako (019–19,741)
PDGFR-β Rabbit 1:200 abcam (ab32570)
CNPase Mouse 1:200 Millipore (MAB326R)
Tuj1 Mouse 1:500 Covance (MMS435P)
Anti-rabbit cy3 secondary
antibody








donkey 1:500 Jackson Immuno Research
(703–545-155)
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Moreover, when the proliferation of ependymal cells is impaired, the
formation of the glial scar after SCI is heavily compromised, detrimen-
tally affecting neuronal survival (Sabelstrom et al., 2013).
Altogether, these reports showed that ependymal cells are the en-
dogenous stem cells in the adult spinal cord and therefore constitute
an attractive cell population to further investigate and target in order
to treat SCI. However, ependymal cells are an understudied cell popula-
tion and how ependymal cells and other endogenous cell populations
inﬂuence each other during glial scar formation is unknown, especially
during pre-adult (juvenile) stages.
Taking advantage of inducible and non-inducible FoxJ1 transgenic
mouse lines, where transgene expression is restricted to cells with mo-
tile cilia and thereby speciﬁcally targets ependymal cells in the spinal
cord (Meletis et al., 2008; Barnabe-Heider et al., 2010), we have investi-
gated the developmental origin and stem cell potential of ependymal
cells during juvenile stages. We demonstrated that the ﬁrst appearance
of ependymal cells around the central canal is at embryonic day (E) 15.5
and that, at early postnatal age, ependymal cells fully surround the cen-
tral canal. We also showed that the in vitro spinal cord stem potential is
conﬁned to ependymal cells from postnatal day (P) 10, and that this po-
tential decreases over time. More interestingly, and in contrast to the
situation in adults (Barnabe-Heider et al., 2010; Sabelstrom et al.,
2013), we show that juvenile (P21) ependymal cells respond to severe
but not mild traumatic SCI in vivo, and that this reduced response is ac-
companied by an increased contribution of astrocytes, pericytes andmi-
croglia. By using FoxJ1-CreERT2-Rasless::YFP mice to speciﬁcally block
theproliferation of ependymal cells (Sabelstromet al., 2013),we further
conﬁrm that the juvenilemice has greater self-recovery potential due to
higher reactivity of other glial cells.
Our experiments reveal that juvenilemice have a higher intrinsic re-
generative potential and that they respond to SCI in an age- and lesion
depth-dependent manner, greatly inﬂuenced by the environment.
2. Materials and Methods
2.1. Mice
All experiments were conducted in accordance with the guidelines
of the Swedish Board of Agriculture (ethical permit N329/11, N217/
14) and were approved by the Karolinska Institutet Animal Care Com-
mittee. We used the tamoxifen-inducible FoxJ1-CreERT2::YFP transgen-
ic mice (Ostrowski et al., 2003; Jacquet et al., 2011; Jacquet et al., 2009).
The FoxJ1 promoter is highly expressed by ependymal cells in the cen-
tral nervous system from development to adulthood. FoxJ1-CreERT2-
Rasless::YFP mice were used to speciﬁcally delete the N-, K-, H-ras
genes to block the proliferation of ependymal cells (Sabelstrom et al.,
2013). To induce recombination, we injected 60 mg/kg of body weight
once daily for 5 and 3 days in adult and juvenile mice, respectively.
Clearance of tamoxifen was allowed for 5 days before the start of the
spinal cord injury experiments. Embryonically and early postnatally, ta-
moxifen at the same concentration was injected intraperitoneally to
pregnant mice or pups' dam from embryonic day E13–14, E15–17,
E17–18, postnatal day P0–P4 and P5–P9. These animals were sacriﬁced
one day after the last injection. Non-inducible FoxJ1-EGFP (Ostrowski et
al., 2003) with FoxJ1 promoter driving GFP expression were used for
embryo collection at E13.5, E15.5, E17.5, P0, P5 and P10.
2.2. Surgical Procedure and Postoperative Care
Mice were kept under anesthesia with a mixture of 2% isoﬂurane
(Baxer) and 1 l/min O2. Body temperature was maintained around
37 °C–38 °C keeping the animals on a thermo-pad for the entire surgery.
The back of the animal was shaved and disinfected with 70% EtOH. The
skin was incised, the superﬁcial fat gently shifted and the muscle tissue
dissected to expose laminae T9–T11. A T10 laminectomy wasperformed and the dura mater was removed. A dorsal funiculi transec-
tion or a dorsal hemisection were performed with a microknife (FST).
After surgery, mice were placed back in their home cages. Mice
underwent daily checks for general health, mobility within the cage,
wounds, swelling, infections or autophagy of the toes. The animals
showed neither skin lesions, infection nor autophagy throughout the
study. Bladders were manually expressed after operation until needed.
2.3. Tissue Preparation and Sectioning
At the end of the survival period, the animals were deeply anesthe-
tized with sodium pentobarbital (APL) (150 mg/kg body weight) and
perfused transcardially with 0.1 M PBS, pH 7.4, and 4% PFA in PBS,
pH 7.4 (Life Technologies). Dissected spinal cords were further
postﬁxed in 4% PFA in PBS at 4 °C overnight and cryoprotected in 30%
sucrose (Life Technologies) for at least 48 h. After embedding in Tis-
sue-Tek OCT compound (Sakura), the spinal cords were cut sagittally
or coronally to 16 μm thickness. Sectionswere collected 1:12 according-
ly to stereological principles and stored at−20 °C until further use.
2.4. Immunohistochemistry
Full details of the primary antibodies used are reported in Table 1.
Spinal cord sections were blocked with 10% normal donkey serum
(Jackson Immunoresearch), 0.3% Triton X-100 (Sigma) in PBS for 1 h
at room temperature. Primary and secondary antibodies were diluted
in 2% BSA (bovine serum albumin; Sigma), 0.2% Triton X-100 PBS. Pri-
mary antibodies were incubated at room temperature overnight and
secondary antibodies were incubated for 1 h. Secondary antibodies
were conjugated with Alexa Fluor ﬂuorophores. Counterstaining was
performedwith DAPI (1:10,000) in PBS and sections were coverslipped
with Vectashield mounting media (BioNordika).
2.5. Neural Stem Cell Cultures
2.5.1. Culture
Animals were sacriﬁced for control culture or one week after SCI.
Spinal cord cells were dissociated and neurosphere cultures were
established as described (Meletis et al., 2008). All cells isolated from
one spinal cord were plated in 10 cm culture dishes. First, neurospheres
were harvested after 2 weeks in culture and then were dissociated into
single cells for passage or differentiation. Approximately 100,000 cells
per animal were plated in a 10 cm culture dish for the next generation
of neurospheres, and all the new neurospheres (second, third and
fourth generations)were harvested after oneweek in culture. Dissociat-
ed primary neurospheres, approximately 50,000 cells/well, were plated
in poly-D-lysine-coated chamber slides (Sigma) for differentiation with
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Two to four independent experiments per group were performed.2.5.2. Immunocytochemistry
After two-week's primary neurosphere culture, approximately 300–
500 recombined neurospheres were plated in poly-D-lysine-coated
chamber slides for one day, followed by immunocytochemistry for
quantiﬁcation of recombined neurospheres with anti-GFP antibody.
For differentiation assay, after 10 days in growth factor-free differentia-
tion condition, immunocytochemistrywas performed as describedwith
antibodies as listed in Table 1.2.5.3. Cell Culture Analysis
For neurosphere assay, neurosphere media was taken 4 times ran-
domly from one culture dish (250 ml per time) and the number of
neurospheres were counted; therefore, the total numbers of
neurospheres was calculated with total volume of media (11–14 ml
per dish). For differentiation assays, after immunocytochemistry, quan-
tiﬁcation of the percentage of markers was randomly recorded with at
least 6 views (20× objective magniﬁcation) per well under ﬂuores-
cence. At least two wells for one marker per animal were used forFig. 1. Ependymal cells appear at mid-embryonic stage in the developing mouse spinal co
central canal (dashed lines) of tamoxifen recombined FoxJ1-CreERT2::YFP. YFP expression is
Embryonic or postnatal spinal cords were collected at E15.5, E18.5, E19.5, P5 and adult (con
cells around the central of non-inducible FoxJ1-EGFP spinal cords at different developmental s
images of FoxJ1+ ependymal cells stained for precursor marker sox9 and vimentin, astrocy
embryonic stage E17.5 or postnatal spinal cord at P2. Scale bar =25 μm. E = embryonic day,
co-staining of GFP and Ki67.quantiﬁcation. The total number of cells was obtained counting all nu-
clei stained with DAPI.2.6. Image Acquisition and Tissue Analysis
Confocal representative images of the lesion site and spinal cords
were acquired using the Zeiss LMS700microscope setup. Quantiﬁcation
of the lesion and cell inﬁltration areas was performed using the Zeiss
AxioSkop2 microscope setup and AxioVision software. The areas were
measured at the epicenter of the lesion. Quantiﬁcation of the number
of cells were performed using the Zeiss Apotome2 microscope setup.
The quantiﬁcation of cells was performed in 2–4 sections per animal.
For each experimental group and staining, 3–9 animals were analyzed.2.7. Statistical Analysis
Statistics were run with Student's t-test for comparing two groups
and Student's t-test with Bonferroni's correction for more than two
groups' comparisons. For all the data analysis, Student's t-test with or
without Bonferroni's correction or one-way ANOVA with Bonferroni's
multiple comparison was used as indicated (*P b 0.05, **P b 0.01,rd. (A) Representative coronal section images of YFP labeled ependymal cells around the
induced by tamoxifen at E13.5–14.5, E15.5–17.5, E17.5–18.5, P0–4 and adult (control).
trol), respectively. (B) Representative coronal section images of GFP labeled ependymal
tages (E14.5, E15.5, E17.5 and P2) and adult (control). (C) Representative coronal section
te marker GFAP, proliferation marker Ki67 and oligodendrocyte marker sox10 of either
P = postnatal day. Dashed lines indicate ventricular zone/ central canal. Arrows indicate
58 X. Li et al. / EBioMedicine 13 (2016) 55–65
59X. Li et al. / EBioMedicine 13 (2016) 55–65***P b 0.001). For each experimental group and staining, 3–9 animals
were analyzed.
3. Results
3.1. Ependymal Cells Appear at Mid-Embryonic Stage in the Developing
Mouse Spinal Cord
It has been shown that ependymal cells are the only cells retaining
stem cell potential in the adult spinal cord (Meletis et al., 2008;
Barnabe-Heider et al., 2010) but the generation of ependymal cells dur-
ing development in the mouse spinal cord has not been characterized.
To study the appearance of ependymal cells in the developing mouse
spinal cord, we used both inducible and non-inducible FoxJ1 promot-
er-driven transgenic mouse lines to speciﬁcally label ependymal cells
(Meletis et al., 2008; Ostrowski et al., 2003; Jacquet et al., 2011;
Jacquet et al., 2009). In order to identify the appearance of ependymal
cells during development, we induced YFP expression in ependymal
cells via tamoxifen-dependent recombination in FoxJ1-CreERT2::YFP
mice at different embryonic and postnatal developmental windows:
embryonic day (E) E13.5–14.5, E15.5–17.5, E17.5–18.5 and postnatal
day (P) P0–4 (Fig. 1A). Embryonic or postnatal spinal cords were col-
lected one day after the last tamoxifen administration.
Analysis of YFP expression revealed that FoxJ1+ cells ﬁrst appear
around the central canal in the E15.5-E17.5 window (Fig. 1A), which
was conﬁrmed using the non-inducible FoxJ1-EGFP transgenic mouse
line, where the reporter protein EGFP labels exclusively ependymal
cells but not their progeny (Fig. 1B). FoxJ1-EGFP mice were sacriﬁced
at different time points during embryonic development and early post-
natal age, and similarly, we found that the ﬁrst GFP+ cells appeared at
E15.5 (Fig. 1B). In both animalmodels, the labeled cells showed the typ-
ical morphology of adult ependymal cells (Fig. 1A,B) (Bruni and Reddy,
1987). As development proceeded, the number of reporter-expressing
cells increased until postnatal stages (P0-P5), when GFP+ cells fully
surround the central canal, similarly to adulthood (Fig. 1A).
We further conﬁrmed that GFP+ cells are ependymal cells by the
expression of the classical markers Sox9 and Vimentin. Some of these
cells also expressed Ki67+, showing that proliferation of ependymal
cells continues after their differentiation (Fig. 1C). Moreover, during
embryonic and early postnatal stages, none of the GFP+ cells express
astrocytic (GFAP) or oligodendrocytic (Sox10)markers (Fig. 1C), further
conﬁrming their ependymal cell identity.
3.2. Higher Self-Renewal Potential of Ependymal Cells during Development
and after SCI In vitro
It has been described that neural stem cells, including adult
ependymal cells in the spinal cord, are able to generate neurospheres
in vitro, and thedissociated cells fromneurospheres can further generate
newneurospheres (Weiss et al., 1996). Using this neurosphere assay can
reveal the degree of self-renewal capacity of stem cells. To studywheth-
er all or only part of the newly born ependymal cells have self-renewal
potential, we used FoxJ1-CreERT2::YFPmice to perform neurosphere as-
says. Embryos at different time points and early postnatal pups were
sacriﬁced after two or ﬁve days of tamoxifen administration to pregnant
or lactating mothers, respectively. Almost the full embryonic spinal
cordswere dissociated for neurosphere assay, and a small cervical spinal
cord biopsy from the same animal was kept for immunohistochemistryFig. 2. Juvenile ependymal cells showa greater self-renewalpotential thanadult in control c
vitro fromFoxJ1-CreERT2::YFPmice. (B) Quantiﬁcation of recombined neurospheres in vitro and
E18.5 (tamoxifen administration at E15–17) and P10 (tamoxifen administration at P5-P9) recom
in fold change of neurospheres grown in culture from spinal cords at the indicated ages and ex
based on the number of neurospheres per 10,000 cells plated of cell extracted from P21 contr
tertiary and fourth neurosphere passages, respectively. A = adult. Ctrl = control. P = postn
value: * ≤ 0.05, ** ≤ 0.01, *** ≤ 0.001. Student's t-test with or without Bonferroni's correct
independent cultures were performed for each condition.to compare the in vitro/in vivo recombined ratios. Recombined
neurospheres or cells indicated neurospheres derived from ependymal
cells in vitro or ependymal cells in vivo, respectively. Analysis showed
that the ratio of recombined neurospheres was similar to the ratio of
recombined-ependymal cells at the same time points, meaning that all
the ependymal cells have self-renewal potential. More importantly,
the number of cells expressing the YFP reporter drastically increased
from E15–17 to P5–10 (Fig. 2A and B) (Meletis et al., 2008).
To conﬁrm the self-renewal capacity of newly born ependymal cells,
we serially passaged the ﬁrst recombined neurospheres. We found that
the earliest-born recombined neurospheres (E18.5, tamoxifen induced
at E15.5–17.5), grew with passages and postnatally, by P10, all
recombined neurospheres maintained their ratio over passages (Fig.
2C). These data suggest that all the newly-born ependymal cells have
self-renewal potential and are able to maintain it, and that the self-re-
newal potential is conﬁned to ependymal cells in the spinal cord from
an early postnatal stage.
To further investigate the self-renewal potential of ependymal cells
and the effect of SCI during postnatal development, we cultured
neurospheres from P10, P21 (juvenile) and adult mouse spinal cord. In
our experiments, we deﬁned a “unit of self-renewal potential” as the
ratio between the numbers of neurospheres generated per 10,000 pri-
mary cells plated. We set the ratio obtained from P21 control cultures
as one-fold for further comparisonwith the other conditions. In primary
neurosphere culture, we observed that during the postnatal develop-
ment, the self-renewal potential of ependymal cells signiﬁcantly de-
creased by approximately 14-fold (P10 vs. P21) and 4-fold (P21 vs.
adult), respectively (Fig. 2D).
Despite the dramatic decrease of self-renewing ependymal cells from
mature adults, this potential can be highly recruited after SCI by showing
more neurospheres (Barnabe-Heider et al., 2010). Given the higher self-
renewal ability of juvenile (P21) spinal cord ependymal cells and the ben-
eﬁcial effect of the recruitment of spinal cord ependymal cells after adult
SCI, we investigated whether juvenile ependymal cells show an even
higher self-renewal ability after SCI. We performed dorsal funiculus tran-
section on both P21 and adult mice at thoracic (T) 10 level. Spinal cords
were collected for primary cell cultures oneweek after injury. The self-re-
newal potential unit of P21 non-injured groupwas deﬁned as one-fold, as
described above. When we compared P21 and adult cultures prepared
from injured spinal cords,we observed aﬁve-fold increase in self-renewal
potential between different conditions: speciﬁcally including non-injured
P21 vs. non-injured adult, P21 injured vs. adult injured, P21 injured vs.
P21 non-injured conditions (Fig. 2D). Furthermore, when we passaged
the neurosphere cultures for four generations, we observed that the effect
of injury on the self-renewal potential was gradually lost (Fig. 2D). These
data indicate that SCI can highly increase the self-renewal capacity of
ependymal cells at both timepoints but only temporally, and that juvenile
ependymal cells have a higher recruitment potential after SCI than adult
ones.
3.3. Juvenile Ependymal Cells ShowHigher Oligodendrogenesis Potential af-
ter SCI In vitro
To characterize the potential of differentiation in vitro during devel-
opment and after injury, spinal cord primary neurospheres were har-
vested, dissociated and cultured in differentiation media at different
developmental stages (E18.5, P10, P21), adulthood and after SCI (P21
and adulthood). We observed that E18.5 primary neurospheres canonditions and after SCI in vitro. (A) Representative image of a recombinedneurosphere in
recombined ependymal cells in vivo. Rec+=recombined. (C) Quantiﬁcation of the ratio of
bined neurospheres over the total number of neurospheres in culture. (D) Quantiﬁcation
perimental conditions during four generations of neurosphere. One-fold change is deﬁned
ol spinal cords. Folds are shown ±SEM. First, second, third, fourth = primary, secondary,
atal day. SCI = spinal cord injury. N = 4–11 animals/condition. Scale bar = 100 μm. P-
ion or one-way ANOVA with Bonferoni's multiple comparison was used. Two to four
Fig. 3. Juvenile ependymal cells show higher differentiation potential towards the oligodendrocytic lineage. (A-C) Representative images of E18.5 spinal cord primary stem cell
culture after 10 days of differentiation (FoxJ1-CreERT2::YFP mice). This culture can generate differentiated (A) astrocytes (GFAP and Sox9), (B)oligodendrocytes (CNPase) and (C)
neurons (Tuj1). (D) Quantiﬁcation (by percentage) of the expression of CNPase + oligodendrocytes from differentiated primary neurospheres during postnatal development,
adulthood and after SCI. (E) Quantiﬁcation (by percentage) of the expression of Tuj1+ cells from primary differentiated neurospheres during postnatal development, adulthood and
after SCI. Percentages are shown ±SEM. P-value * ≤ 0.05, ** ≤ 0.01. Scale bar = 100 μm. N = 3–4 animals per condition. A minimum of 500 cells were counted per each condition.
A = adult. Ctrl = control. SCI = spinal cord injury, CNPase = cyclic nuecleotide phosphodiesterase, Tuj1 = neuron-speciﬁc beta III tubulin. Student's t-test with or without
Bonferroni's correction or one-way ANOVA with Bonferoni's multiple comparison was used. Two to four independent cultures were performed for each condition.
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cytes (YFP+/CNPase+ cells) and neurons (YFP+/Tuj1+ cells) (Fig.
3A–C). However, ependymal cells gradually lose the capability to differ-
entiate into oligodendrocytes. Indeed, we observed almost 10-fold de-
crease between P10 to P21 and to adulthood (Fig. 3D).
Interestingly, from a therapeutic perspective, we observed that SCI
enhances differentiation into oligodendrocytes of both P21 and adult
ependymal cells by almost 5-fold compared to non-injured conditions
whenneurospheres are grown in serum(Fig. 3D).Moreover, P21-derived
generated more oligodendrocytes than adult-derived neurospheres after
SCI. These observations may have positive implications for the
remyelination potential of juvenile compared to adult spinal cords after
traumatic injury. However, the capacity to generate neurons (Tuj1+
cells) only displayed a decreasing tendency without statistical signiﬁ-
cance during development from P10 to P21 and to adult (Fig. 3E). SCI in-
creased neurogenesis from ependymal cells in vitro mildly, while the
more profound effect recorded was on oligodendrocyte generation. The
differentiation data suggest that the intrinsic differentiation capability
of ependymal cells to other cell types varies during development and
after SCI and preferentially stirs towards gliogenesis.
3.4. The Recruitment of Ependymal Cells at the Injury Site Is Age- and Lesion
Depth-Dependent
Previous studies showed that adult ependymal cells are activated
and recruited at the lesion site in a similar manner after both mild and
severe traumatic SCI (Barnabe-Heider et al., 2010; Sabelstrom et al.,
2013). We investigated whether a similar or different pattern of migra-
tion and activation was observed in juvenile (P21) spinal cord.
We used the FoxJ1-CreERT2::YFP mouse model to fate map the
ependymal cells and follow their progeny activation and migration
after SCI in juvenile and adult mice. Five days after tamoxifen-induced
speciﬁc expression of the YFP reporter in ependymal cells, weperformed mild or severe SCI at mid-thoracic level (T9–10) in juvenile
(P21) and adult (2–5 months old) mice. We used dorsal funiculi tran-
section (DFT) and dorsal hemisection (DH) as mild and severe SCI
models, respectively (Cheriyan et al., 2014; Kwon et al., 2002). Animals
were then sacriﬁced oneweek or fourmonths after lesion to investigate
contribution of ependymal-derived progeny and anatomical changes
during both post-injury acute and chronic phases.
Previous reports showed that adult ependymal cells are massively
recruited towards the lesion site after SCI (Barnabe-Heider et al.,
2010; Okada et al., 2006). Here, we also observed that adult ependymal
cells migrate towards themiddle of the lesion site after SCI (Fig. 4A,B,E).
Surprisingly, juvenile ependymal cells were recruited only after severe
(DH) and not mild (DFT) SCI (Fig. 4A,B,E). The total number of
recombined ependymal cells was comparable in the animals at the dif-
ferent ages tested with a different distribution between the cells re-
maining around the central canal and those having migrated to the
lesion site (Fig. 4C), assuring that the effect on migration we observed
was not due to recombination artifacts.
3.5. The Scar Formation and the Lesion Environment Affect the Recruitment
of Ependymal Cells
SCI induces activation and recruitment of several cell types, includ-
ing astrocytes, microglia, blood-derived macrophages and stromal
cells (ﬁbroblasts and pericytes). Therefore, we analyzed other aspects
of glial scar formation in order to further understand the different re-
sponses of P21 and adult ependymal cells.
Firstly, the lesion area after SCI can be subdivided in a lesion core
where reactive astrocytes do not inﬁltrate and an astrogliotic area
where reactive astrocytes accumulate. We observed that the lesion core
areawas smaller in juvenile than adultmice following DFT (Fig. 4A,D), in-
dicating that juvenile spinal cord can seal the lesion site more efﬁciently
than adult after mild injury (P b 0.01 at 1 wpi and P b 0.05 at 4 mpi). In
Fig. 4. Ependymal cells recruitment depends on age and spinal cord lesion depth. (A,B) Representative pictures of coronal spinal cord sections of adult DFT, P21 DFT, adult DH and P21
DH spinal cord 1 week after injury and adult DFT and P21 DFT 4 months after SCI (FoxJ1-CreERT2::YFP mice). Sections were stained with GFP, GFAP and DAPI. (C) Quantiﬁcation of the
number of ependymal cells around the central canal and at the lesion site in juvenile and adult spinal cords one week after DFT or DH. (D) Quantiﬁcation ((by percentage) of the
extension of the lesion core and (F) astrogliosis areas in juvenile and adult spinal cords one week and four months after DFT or DH. (E) Summary table showing the correlation
between ependymal cells migration towards the lesion site and age or lesion depth. Scale bars are 100 μm. Full and dashed lines outline lesion core and astrogliotic area, respectively
and were used for quantiﬁcation. Percentages are shown ±SEM. P-value * ≤ 0.05, ** ≤ 0.01, *** ≤ 0.001. Only statistical signiﬁcance were marked with *, otherwise no signiﬁcance.
P21 = postnatal day 21, A = adult, DFT = dorsal funiculi transection, DH = dorsal hemisection, CC = central canal, ECs = ependymal cells, wpi = week post-injury, mpi = months
post-injury. Few migrating ECs = b5 ECs in the lesion site/section. N= 3 to 10 animals per condition. Student's t-test with or without Bonferroni's correction was used.
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a severe injury (DH) was performed in juvenile animals (Fig. 4A,D).
Secondly, since astrocytes also contribute to the sealing of the lesion
site (Okada et al., 2006), we measured the area of astrogliosis around
the core of the lesion. We observed an astrogliosis area smaller or sim-
ilar to adult when a mild (DFT) (P b 0.001) or severe (DH) injury was
performed in juvenile animals (Fig. 4F), respectively. Importantly, we
did not observe a statistically signiﬁcant difference in lesion core or
astrogliosis areas in adult mice following mild (DFT) or severe (DH) in-
juries (Fig. 4A,D,F). Altogether, our data suggest that the size of the le-
sion impacts the migration of ependymal cells in juvenile mice.
Activated microglia and blood-derived macrophages are heteroge-
neous cell populations. They are subdivided inM1 andM2macrophages
that show proinﬂammatory and anti-inﬂammatory properties, respec-
tively (Kigerl et al., 2009). This importantly affects the self-repair prop-
erties of the spinal cord after injury. Moreover, pericytes have recently
emerged as a pivotal cell type in sealing the lesion following SCI
(Goritz et al., 2011).
To assess whether microglia, blood-derived macrophages and stro-
mal cells can also inﬂuence the age- and lesion-dependent differential
recruitment of ependymal cells after SCI, we stained the lesion site of ju-
venile and adult mice after mild and severe SCI for Iba1 and PDGFRβ,
markers of microglia-macrophages and stromal cells, respectively.
Similarly to our analysis of the lesion area, we measured a smaller
area inﬁltrated by activated microglia and blood-derived macrophages
(P b 0.05) or stromal cells (P b 0.05) at the lesion site in juvenile com-
pared to adult mice after DFT (Fig. 5A–D). We also observed Iba1+
and PDGFRβ+ areas comparable to adult only after performing a severe
lesion in juvenile mice (Fig. 5A–D). Iba1 analyses were performed also
at 4 mpi (month post-injury). However, during the chronic phaseafter SCI, the inﬂammatory response retrogresses and we did not ob-
serve any signiﬁcant activation of microglia/blood-derived macro-
phages (data not shown). Altogether, this suggests that the glial scar
formation is signiﬁcantly different in juvenile and adult mice due to
the differential response of the other glial cell populations and pericytes.
3.6. Lesion Sealing Is More Efﬁcient and Ependymal-Cell Independent in Ju-
venile than Adult Spinal Cord
Adult ependymal cells contribute to sealing and restrict second en-
largement of the lesion (Sabelstrom et al., 2013). Our data in juvenile
mice showed that ependymal cells are recruited to the lesion site de-
pending on the severity of the injury. Therefore, we assessed the contri-
bution of juvenile ependymal cells to the sealing and restriction of
secondary enlargement in juvenile animals taking advantage of the
FoxJ1-CreERT2-Rasless::YFPmousemodel. In this mouse model, remov-
al of the Ras genes in ependymal cells blocks their cell cycle and prolif-
eration after SCI (Sabelstrom et al., 2013).
We performed DH in juvenile and adult mice and sacriﬁced the ani-
mals one month after injury when the injury depth reaches its maxi-
mum and no further enlargement is observed (Sabelstrom et al.,
2013).We stained for GFAP and PDGFRβ in order to visualize the border
of the lesion and the stromal cap, respectively. We observed that when
ependymal cells could not be activated in juvenile or adult mice, the le-
sion was properly sealed in all the analyzed juvenile animals while 50%
of the adult mice showed a cavity (Fig. 6A-C). We also quantiﬁed the
astrogliotic area and the inﬁltrating stromal cell area. For normalization,
we set the areas measured on animals injured at P21 as 100%.
We found that both astrogliosis and stromal inﬁltration areas at the
injury site of animals injured at P21 were signiﬁcantly smaller than
Fig. 5. Activation of microglia/macrophages and scar-forming stroma cells inﬁltration depends on age and spinal cord lesion depth. Representative pictures of coronal spinal cord
sections of adult DFT, P21 DFT and P21 DH spinal cord (FoxJ1-CreERT2::YFPmice): (A,B) activatedmicroglia/macrophages area (Iba1+ area) and quantiﬁcation of Iba1+ area 1 week after
injury, (C-E) pericyte-derived stromal cells area (PDGFRβ+) and quantiﬁcation of PDGFRβ+ area 1 week or 4 months after injury. Quantiﬁcation was shown in percentage. Scale bars are
100 μm.Dashed and full lines outline the reactive Iba1+ cells and pericyte areas of inﬁltration, respectively andwere used for quantiﬁcation. Percentages are shown±SEM. P-value * ≤ 0.05,
** ≤ 0.01. Only statistical signiﬁcanceweremarkedwith *, otherwise no signiﬁcance. P21=postnatal day 21, A=adult, DFT=dorsal funiculi transection,DH=dorsal hemisection,wpi=
week post-injury, mpi = months post-injury. N= 3 to 9 animals per condition. Student's t-test with or without Bonferroni's correction was used.
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ﬁrm that in juvenile mice, ependymal cells are not recruited because
other glial cells have sufﬁcient lesion sealing properties. This suggests
that ependymal cells are the spinal cord endogenous reservoir to pro-
mote self-repair when severe injury occurs and in adulthood.
In summary, our data showed that the formation of the glial scar
after SCI is inﬂuenced by both themouse age and severity of injury. Fur-
thermore, we showed that juvenile ependymal cells, the stem cells of
the spinal cord, have higher intrinsic stem cell potential than adult
ones. However the potential for self-repair and regeneration is highly
inﬂuenced by age and the lesion environment.
4. Discussion
We have studied and characterized the potential of ependymal cells
during development and after SCI. By comparing the in vivo and in vitro
recombined ratios of FoxJ1-CreERT2::YFP mouse line during embryonic
and early postnatal development, we found that in vitro spinal cord
stem cell potential is gradually conﬁned to ependymal cells starting
from their embryonic appearance at E15.5. The self-renewal potential
is all conﬁned to ependymal cells from P10, but the capability of self-re-
newal dramatically decreases after postnatal development and en-
hanced by SCI.
Juvenile ependymal cells have higher intrinsic stem cell potential
than adults both before and after SCI in vitro. However, in vivo
ependymal cells react as a backupmechanism for self-repair and get re-
cruited when the other glial cell types fail to seal the lesion. This sug-
gests that there might be higher self-repair potential in juvenile than
adult spinal cords.
In the spinal cord, ependymal cells originate at mid embryonic
stages (E15.5) and completely surround the central canal by birth
(P0). Two waves of ependymogenesis have been described in rats: theﬁrst seems to derive from radial glial progenitors during embryonic de-
velopment (E17.5) and the second wave is formed during postnatal life
(Qin et al., 2015). However, most studies on ependymogenesis have
been based on immunohistochemistry analysis with pan markers of
ependymal and astrocytic progenitor cells, such as Sox9 and Vimentin.
These markers lack speciﬁcity and do not allow precise birth-dating of
mature ependymal cells. More importantly, this has limited further
study of the stem cell potential of endogenous ependymal cells during
spinal cord development and upon injury.
To determine the developmental time point at which mouse
ependymal cells arise in the spinal cord, we took advantage of inducible
FoxJ1-CreERT2::YFP and non-inducible FoxJ1-EGFP transgenic mouse
lines. FoxJ1 promoter-driven reporter expression can speciﬁcally label
ependymal cells in the adult spinal cord (Meletis et al., 2008;
Barnabe-Heider et al., 2010). We showed that recombined ependymal
cells line around the central canal the earliest at E15.5 in themouse em-
bryonic spinal cord. Combining with the markers previously used to
characterize ependymal cells (Sox9 and Vimentin), we conﬁrmed that
ependymal cells ﬁrst appear inmouse spinal cord at E15.5, and virtually
fully surround the central canal by P10, while showing proliferative
activity.
Neurosphere assay reveals the self-renewal potential of neural stem
cells. Our data showed that virtually all neurospheres are derived from
ependymal cells from P10 to adulthood, indicating that the spinal cord
stem cell potential is fully conﬁned to ependymal cells from a very
young age. We suggest that therapies targeting endogenous stem cells
after SCI should focus on ependymal cells. Our neurosphere assay
showed that juvenile have a greater self-renewal potential than adult
ependymal cells and are more highly recruited after SCI. Previous stud-
ies have suggested that neural stem cells lose their stem cell potential
during ageing and after traumatic brain injury (Sun et al., 2005;
Conover and Shook, 2011). Our data are in line with these studies.
Fig. 6. Activation of ependymal cells is not required to seal the lesion site in juvenile spinal cords. (A,B) Representative picture of longitudinal spinal cord sections of the lesion site
epicenter in juvenile and adult spinal cord one month after dorsal hemisection (FoxJ1-CreERT2-Rasless::YFP mice). Tissues were stained by GFAP and PDGFRβ. (C) Summary table
showing the correlation between age, lesion sealing and ependymal cells activation. Scale bars are 100 μm. (D) Quantiﬁcation (by percentage) of reactive astrocyte (GFAP+) and
pericyte-derived stromal cells (PDGFRβ+) area. P21 GFAP+ or PDGFRβ+ area were set as 100% for normalization. Percentages are shown ±SEM. P-value * ≤ 0.05, ** ≤ 0.01. Only
statistical signiﬁcance were marked with *, otherwise no signiﬁcance. Dashed lines outline the astrogliotic lesion border. Full lines outline the non-astrogliotic lesion cord or the
inﬁltration area by pericyte-derived stromal cells. P21 = postnatal day 21, A = adult, DH = dorsal hemisection, mpi = months post-injury. N = 3 to 6 animals per condition.
Student's t-test with or without Bonferroni's correction was used.
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higher recruitment of juvenile than adult ependymal cells after SCI.
Juvenile ependymal cells also display a higher potential of differentia-
tion into oligodendrocytes compared to adult bothprior or after SCI. How-
ever, the potential of generating neurons is not dramatically affected by
different ages or by SCI in vitro. Previous work has shown that embryonic
spinal cord stem cells and adult ependymal cells give rise to different pro-
portions of neural cell types (Kalyani et al., 1997; Barnabe-Heider et al.,
2010), our data support that further therapies should focus on the recruit-
ment of ependymal cells and their differentiation to oligodendrocyte
rather than into neurons to increase functional recovery. Previous studies
showed that exogenous growth factors can modulate oligodendrocyte
proliferation and suggested that this would be a beneﬁcial target for fur-
ther drug discovery and therapies for SCI (Corns et al., 2015). Our data
agrees with this argument and further indicates that modulating stem
cell differentiation towards the oligodendrocyte lineagewill be inﬂuenced
by age-dependent differences in intrinsic stem cell potential.
Ependymal cells respond to SCI bymigrating towards the core of the
lesion site, where they give rise to astrocytes and, to a smaller extent,oligodendrocytes (Barnabe-Heider et al., 2010). It has been suggested
that ependymal cell-derived astrocytes positively contribute to the
self-repair of the injured spinal cord (Sabelstrom et al., 2013). However,
the self-recovery potential of the spinal cord after injury seems to de-
cline during ageing (DeVivo et al., 1990; Furlan et al., 2010; Wyndaele
and Wyndaele, 2006). In this regard, we investigated whether and
how ageing affects the capacity of ependymal cells to respond to injury.
Ependymal cell-derived astrocytes are located at the core of the le-
sion site, while resident astrocytes proliferate and are recruited at the
border of the lesion site after spinal cord injury (Barnabe-Heider and
Frisen, 2008; Burda and Sofroniew, 2014). It was demonstrated that
ageing changes the astrocyte physiology and the sensitivity to oxidative
stress, and age-related astrocytic changes in the central nervous system
results in reduced VEGF and FGF-2 signaling, which in turn limits neural
stem cell and progenitor cell maintenance and contributes to decreased
neural stem cell potential (Bernal and Peterson, 2011; Lin et al., 2007).
We observed that juvenile ependymal cells are not recruited to the
lesion site in vivo after mild SCI in juvenile mice. In parallel, we also ob-
served that the sealing of the lesion is more efﬁcient in juvenile
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This suggests that juvenile resident astrocytesmay contribute to sealing
the lesion more efﬁciently than during adulthood. This may lead to a
more pro-regenerative environment and the activation, recruitment
and differentiation of ependymal cells into astrocytes is not required
in juvenile mice as much as during adulthood following SCI. However,
in case of severe SCI, juvenile ependymal cells migrate towards the
core of the lesion site, showing the same phenotype that was previously
described in response to both mild and severe SCI in adult mice
(Barnabe-Heider et al., 2010; Sabelstrom et al., 2013).
Importantly, one previous study showed that blocking the recruit-
ment and proliferation of adult ependymal cells results in development
of large cysts at the lesion sites, implying that ependymal cell progeny
functions as a scaffold within the scar to restrict secondary enlargement
of the lesion after the initial insult (Sabelstrom et al., 2013). We showed
here that when the cell cycle is blocked in juvenile ependymal cells, no
cysts develop in the mouse spinal cord after severe SCI. This supports
the idea that juvenile ependymal cells play a secondary role in the
sealing and enlargement of the lesion site as other glial cell populations
are already responding to the lesion. Moreover, this sheds light on the
importance of the environment to efﬁciently recruit endogenous stem
cells upon SCI.
Altogether, our data show that despite the presence of ependymal
cell stem cell potential in both juvenile and adult spinal cords, they
react in vivo as backup participants in the response to SCI in juvenile
mice, i.e., only when the injury is too severe to be sufﬁciently sealed
by the other resident glial cells, such as astrocytes. This highlights that
efﬁcient modulation of ependymal cells and the glial scar response
both have to be considered in the therapeutic context.
Besides resident astrocytes and ependymal cells, other glial cell
types, including microglia, blood-derived macrophages and stromal
cells, also have amajor role in glial scar formation after SCI and inﬂuence
the reactivity of resident astrocytes (Goritz et al., 2011; Jin and
Yamashita, 2016; Schwartz, 2010). We investigated whether these
mechanisms would also inﬂuence the migration and activation of
ependymal cells in mild and severe SCI in juvenile and adulthood.
During glial scar formation, glial cells inﬂuence each other response
and recruitment to the lesion site (Stenudd et al., 2015). In juvenile
mice, we report that mild SCI results in reduced activation and recruit-
ment of microglia and blood-derived macrophages to the lesion site
compared to their response following severe SCI. Also, the microglia/
blood-derived macrophages activation and recruitment reaches the ex-
tent observed in adulthood only when a severe injury is performed in
juvenile mice. Therefore, we suggest that juvenile reactive astrocytes
are more pro-regenerative than in the adult.
Pericytes are the major cell type forming the ﬁbrotic cap ﬁlling the
lesion site after SCI (Goritz et al., 2011). We observed that in juvenile
mice the stromal cap is reduced in size compared to adult spinal cords
when the same kind of injury is performed. The differences among sev-
eral cells types involved in self-repair reveal that the regenerative and
recovery potential of the spinal cord decreases not only during develop-
ment but also during ageing. That could be due to the age-dependent
transcriptome changes in terms of inﬂammation or metabolism
(Saunders et al., 2014; Noor et al., 2011). Notably, there is clinical evi-
dence that people who have sustained SCI during pediatric rather than
adult ages enjoy better overall health and functional recovery as well
as reduced pain (Ma et al., 2016). Consist with this, our data on the for-
mation of the glial and stromal scars suggest that juvenile spinal cords
have a more pronounced potential for self-repair than adult cords,
which could be highly relevant to the development of optimal individu-
al SCI therapies.
Ourﬁndings of developmental changes in the injury responses of en-
dogenous stem cells have particular therapeutic relevance for SCI. Re-
cruitment of endogenous stem cells is a conceptually different
approach to achieving the functional beneﬁts previously observed
with cell transplantation, which can carry signiﬁcant ethical,tumorigenic and immunological/infectious risks (Barnabe-Heider and
Frisen, 2008; Coutts and Keirstead, 2008). Considering the high preva-
lence of SCI in the teenager/young adult population, better understand-
ing of changing stem cell properties during development and ageing is
essential for developing age-targeted endogenous stem cell approaches.
Indeed, virtually all published studies to date on endogenous spinal cord
stem cells have been conducted using adult and not juvenile animals.
This study opens the door for tackling the challenge of manipulating
proliferation, migration and differentiation of endogenous stem cells
across different age/developmental periods.
In summary, we show age-related differences in ependymal stem
cell potential and contribution to scar formation and sealing of the le-
sion following SCI. Our results highlight that the juvenile spinal cord is
more prone to self-repair, and suggest that recruitment of ependymal
cell occurs mainly when other spinal cord self-repair mechanisms are
insufﬁcient to restrict lesion site damage. Properly tuning the response
of both ependymal and other glial cell populations should be explored
as a way to promote spinal cord repair following SCI.
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